Richard R. Stewart's most recent trade in Kirby Corp. was a trade of 1,923 Common Stock, par value $0.10 per share done . Disclosure was reported to the exchange on May 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Kirby Corp. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 1,923 | 17,411 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Chieve Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.86 per share. | 17 Mar 2025 | 10,000 | 60,876 (0%) | 0% | 2.9 | 28,598 | Common Stock |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Chieve Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 157,500 | 157,500 | - | - | Performance Restricted Stock Unit (PRSU) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Chieve Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
Kirby Corp. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 128.21 per share. | 20 Nov 2024 | 8,000 | 15,488 (0%) | 0% | 128.2 | 1,025,680 | Common Stock, par value $0.10 per share |
Eagle Materials Inc. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 300.30 per share. | 20 Nov 2024 | 3,577 | 1,100 (0%) | 0% | 300.3 | 1,074,173 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 478 | 7,519 (0%) | 0% | 0 | Common Stock | |
Kirby Corp. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 1,828 | 24,164 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
Kirby Corp. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 109.60 per share. | 29 Apr 2024 | 676 | 23,488 (0%) | 0% | 109.6 | 74,090 | Common Stock, par value $0.10 per share |
Kirby Corp. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 99.52 per share. | 25 Apr 2024 | 6,000 | 27,660 (0%) | 0% | 99.5 | 597,120 | Common Stock, par value $0.10 per share |
Kirby Corp. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2024 | 6,000 | 0 | - | - | Director Stock Options (Right to Buy | |
Kirby Corp. | Richard R. Stewart | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.16 per share. | 25 Apr 2024 | 5,324 | 22,336 (0%) | 0% | 112.2 | 597,140 | Common Stock, par value $0.10 per share |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 22,500 | 0 | - | - | Performance Restricted Stock Unit (PRSU) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 22,500 | 61,001 (0%) | 0% | 0 | Common Stock | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.51 per share. | 19 Apr 2024 | 10,125 | 50,876 (0%) | 0% | 4.5 | 45,664 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Apr 2024 | 2,817 | 1,186 (0%) | 0% | 0 | Common Stock | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Mar 2024 | 10,000 | 10,000 | - | - | Common Stock Warrants (right to buy) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.58 per share. | 04 Mar 2024 | 10,000 | 38,501 (0%) | 0% | 4.6 | 45,850 | Common Stock |
Kirby Corp. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 85.62 per share. | 22 Feb 2024 | 3,000 | 21,660 (0%) | 0% | 85.6 | 256,860 | Common Stock, par value $0.10 per share |
Achieve Life Sciences Inc. | Richard Stewart Alistair Balfour | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 140,000 | 140,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
Achieve Life Sciences Inc. | Stewart Alistair Balfour Richard | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
Kirby Corp. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 85.72 per share. | 12 Sep 2023 | 3,000 | 24,660 (0%) | 0% | 85.7 | 257,160 | Common Stock, par value $0.10 per share |
Kirby Corp. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 82.26 per share. | 30 Aug 2023 | 3,500 | 27,660 (0%) | 0% | 82.3 | 287,910 | Common Stock, par value $0.10 per share |
Eagle Materials Inc. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 187.99 per share. | 30 Aug 2023 | 2,000 | 7,041 (0%) | 0% | 188.0 | 375,978 | Common Stock |
Kirby Corp. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 79.77 per share. | 18 Aug 2023 | 1,500 | 31,160 (0%) | 0% | 79.8 | 119,655 | Common Stock, par value $0.10 per share |
Eagle Materials Inc. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 182.28 per share. | 17 Aug 2023 | 1,000 | 9,041 (0%) | 0% | 182.3 | 182,284 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 655 | 10,041 (0%) | 0% | 0 | Common Stock | |
Kirby Corp. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 2,767 | 32,660 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 5,000 | 0 | - | - | Performance Restricted Stock Unit (PRSU) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 5,000 | 30,751 (0%) | 0% | 0 | Common Stock | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.29 per share. | 28 Apr 2023 | 2,250 | 28,501 (0%) | 0% | 8.3 | 18,653 | Common Stock |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 22,500 | 22,500 | - | - | Performance Restricted Stock Unit (PRSU) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 22,500 | 35,876 (0%) | 0% | 0 | Common Stock | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.80 per share. | 21 Apr 2023 | 10,125 | 25,751 (0%) | 0% | 6.8 | 68,850 | Common Stock |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 75,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
Eagle Materials Inc. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 978 | 9,386 (0%) | 0% | 0 | Common Stock | |
Kirby Corp. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 3,113 | 29,893 (0%) | 0% | 0 | Common Stock, par value $0.10 per share | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 5,000 | 15,626 (0%) | 0% | 0 | Common Stock | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 5,000 | 5,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.43 per share. | 28 Apr 2022 | 2,250 | 13,376 (0%) | 0% | 7.4 | 16,718 | Common Stock |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 45,000 | 45,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
Eagle Materials Inc. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 145.95 per share. | 13 Sep 2021 | 6,018 | 8,408 (0%) | 0% | 146.0 | 878,336 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 91.95 per share. | 13 Sep 2021 | 2,703 | 11,111 (0%) | 0% | 92.0 | 248,541 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 2,703 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.28 per share. | 13 Sep 2021 | 1,800 | 12,911 (0%) | 0% | 81.3 | 146,304 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 1,800 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.03 per share. | 13 Sep 2021 | 1,515 | 14,426 (0%) | 0% | 93.0 | 140,940 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 1,515 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Eagle Materials Inc. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 874 | 8,408 (0%) | 0% | 0 | Common Stock | |
Kirby Corp. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 3,048 | 26,780 (0%) | 0% | 0 | Common Stock, par value $.10 per share | |
Eagle Materials Inc. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 125.22 per share. | 05 Mar 2021 | 1,951 | 4,177 (0%) | 0% | 125.2 | 244,307 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 124.29 per share. | 05 Mar 2021 | 1,375 | 6,128 (0%) | 0% | 124.3 | 170,894 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 125.83 per share. | 05 Mar 2021 | 174 | 4,003 (0%) | 0% | 125.8 | 21,895 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Sale of securities on an exchange or to another person at price $ 123.77 per share. | 23 Feb 2021 | 3,924 | 7,534 (0%) | 0% | 123.8 | 485,667 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.21 per share. | 23 Feb 2021 | 2,161 | 9,695 (0%) | 0% | 67.2 | 145,241 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 2,161 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.73 per share. | 23 Feb 2021 | 1,763 | 11,458 (0%) | 0% | 79.7 | 140,564 | Common Stock |
Eagle Materials Inc. | Richard R. Stewart | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 1,763 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Achieve Life Sciences Inc. | Richard Alistair Balfour Stewart | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 10,000 | 10,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
Eagle Materials Inc. | Richard R. Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 1,495 | 7,534 (0%) | 0% | 0 | Common Stock |